Claire Faltermeier MD, PhD

Claire Faltermeier, MD

Expected Graduation Date: 2025

 

 

 

 




Education, Training, and Previous Positions

2006: BA, Biology, Columbia University
2018: MD, PhD: UCLA, David Geffen School of Medicine

Selected Honors and Awards

2016: Scholar-in-Training Award, AACR
2015: Scholar-in-Training Award, AACR
2015: Best Oral Presentation, Annual UCLA Pharmacology Department Symposium

Recent Publications

Drake JM, Graham NA, Lee JK, Stoyanova T, Faltermeier CM, Sud S, Titz B, Huang J, Pienta KJ, Graeber TG, Witte ON. Metastatic castration-resistant prostate cancer reveals intrapatient similarity and interpatient heterogeneity of therapeutic kinase targets. Proc Natl Acad Sci U S A. 2013 Dec 3;110(49):E4762-9. doi: 10.1073/pnas.1319948110. Epub 2013 Nov 18. PubMed PMID: 24248375; PubMed Central PMCID: PMC3856845.

Drake JM, Paull EO, Graham NA, Lee JK, Smith BA, Titz B, Stoyanova T, Faltermeier CM, Uzunangelov V, Carlin DE, Fleming DT, Wong CK, Newton Y, Sudha S, Vashisht AA, Huang J, Wohlschlegel JA, Graeber TG, Witte ON, Stuart JM. Phosphoproteome Integration Reveals Patient-Specific Networks in Prostate Cancer. Cell. 2016 Aug 11;166(4):1041-1054. doi: 10.1016/j.cell.2016.07.007. Epub 2016 Aug 4. PubMed PMID: 27499020; PubMed Central PMCID: PMC4985183.

Faltermeier CM, Drake JM, Clark PM, Smith BA, Zong Y, Volpe C, Mathis C, Morrissey C, Castor B, Huang J, Witte ON. Functional screen identifies kinases driving prostate cancer visceral and bone metastasis. Proc Natl Acad Sci U S A. 2016 Jan 12;113(2):E172-81. doi: 10.1073/pnas.1521674112. Epub 2015 Nov 30. PubMed PMID: 26621741; PubMed Central PMCID: PMC4720329.

Zhao H, Faltermeier CM, Mendelsohn L, Porter PL, Clurman BE, Roberts JM. Mislocalization of p27 to the cytoplasm of breast cancer cells confers resistance to anti-HER2 targeted therapy. Oncotarget. 2014 Dec 30;5(24):12704-14. PubMed PMID: 25587029; PubMed Central PMCID: PMC4350358.

Stoyanova T, Riedinger M, Lin S, Faltermeier CM, Smith BA, Zhang KX, Going CC, Goldstein AS, Lee JK, Drake JM, Rice MA, Hsu EC, Nowroozizadeh B, Castor B, Orellana SY, Blum SM, Cheng D, Pienta KJ, Reiter RE, Pitteri SJ, Huang J, Witte ON. Activation of Notch1 synergizes with multiple pathways in promoting castration-resistant prostate cancer. Proc Natl Acad Sci U S A. 2016 Oct 18;113(42):E6457-E6466. Epub 2016 Sep 30. PubMed PMID: 27694579; PubMed Central PMCID: PMC5081658.

Faltermeier C, Busuttil RW, Zarrinpar A. A Surgical Perspective on Targeted Therapy of Hepatocellular Carcinoma. Diseases. 2015 Sep 29;3(4):221-252. doi: 10.3390/diseases3040221. Review. PubMed PMID: 28943622; PubMed Central PMCID: PMC5548262.

Ghorbal M, Scheidig-Benatar C, Bouizem S, Thomas C, Paisley G, Faltermeier C, Liu M, Scherf A, Lopez-Rubio JJ, Gopaul DN. Initial characterization of the Pf-Int recombinase from the malaria parasite Plasmodium falciparum. PLoS One. 2012;7(10):e46507. doi: 10.1371/journal.pone.0046507. Epub 2012 Oct 8. PubMed PMID: 23056326; PubMed Central PMCID: PMC3466309.